Introduction

After the 13th Five Year Plan and Made in China 2025, the Pharmaceutical Industry Development Planning Guide jointly issued by the six departments emerged. The guideline focuses on the development goals of the pharmaceutical industry during the 13th Five Year Plan period, aiming to accelerate the transformation of the pharmaceutical industry from big to strong. Among them, biopharmaceutics is a key field, and the development direction is clarified in the guide. The golden development period of biological medicine is coming. In 2018, driven by national policies and capital, China's pharmaceutical industry gradually transformed from traditional generic drug production to independent innovative drug R&D and production.

China's biopharmaceutical industry is experiencing very rapid development. It is estimated that by 2022, global biotechnology drugs will account for more than one third of the total drug sales revenue. "2022 Hai International Biopharmaceutical and Technical Equipment Exhibition", in line with the general trend of the booming development of the biopharmaceutical industry, focuses on the display of products and technologies such as genetic engineering, antibody engineering and biological cell engineering, provides the best trade exchange platform for biopharmaceutical companies, new drug research and development enterprises, technical equipment and professionals, and helps boost the unlimited business opportunities in the biopharmaceutical market. Biomedicine has been identified as a "strategic emerging industry" in China and has a strategic position in the national economy. The huge potential of China's biopharmaceutical market has attracted many multinational large pharmaceutical enterprises to intervene, while creating more investment opportunities.

The industry event you can't miss

1. R&D and transformation of biopharmaceuticals: display the latest products, production process optimization, technology and industry solutions in the industry, and professional buyers negotiate with exhibitors closely.

2. Massive business opportunities: more than 10000 elites from large pharmaceutical companies, biopharmaceuticals, antibiotics, vaccines, bioengineering, biotechnology companies, drug production/research and development, scientific research institutes, clinical research companies and other application industries gathered together, and more than 20 international groups from Türkiye, Japan, South Korea, Thailand, India, Indonesia and other countries exchanged and negotiated; Decision makers such as the management and procurement director of globally renowned biopharmaceutical enterprises came to the site to seek business opportunities!

3. Technical Forum: More than 5 technical forums will be held on site, covering more than 20 application industries, and more than 2000 industry experts will be interviewed face to face. It provides a neutral, open and free communication platform for exhibitors, audiences and media.

4. Business matchmaking: For your target user industry, the organizer will specially invite potential buyers one-to-one for you to communicate with you face to face and negotiate purchase.

Comprehensively affect the user industry

The organizer will carry out strong organization and publicity work. At that time, relevant experts and scholars, engineers and technicians, as well as domestic and foreign trade organizations, will be invited to participate in the exhibition, including pharmaceutical companies, biopharmaceuticals, bioengineering, clinical trials, genetic engineering, antibody engineering, cell culture, biological instruments, biotechnology companies, vaccines, antibiotics, pharmaceutical companies, drug production/research and development, laboratories, scientific research institutes, research institutions, etc.

1、 Biopharmacy: antibody, biofuel, bioinformation, bioinformation technology, biological agents, biological manufacturing, biotechnology, business services, cell biology, clinical trials, cloud computing, drug delivery system, new drug research and development, genomics/genetics, intellectual property rights, nanotechnology, individualized drug use, platform technology, regulations/compliance, stem cell research, technology transfer, therapeutics, vaccines, etc;

2、 Technical equipment: laboratory fermentation tank, micro automatic fermentation tank, cell tank, vaccine (bacteria) fermentation tank, glass fermentation tank, cell culture system (instrument), cell reactor, bioreactor (cell tank), airflow/magnetic stirring, online detector, automatic cell culture reactor, cell (bacteria, vaccine, microorganism) analyzer, cell incubator, shaking table, incubator, fermentation system control software Cell engineering monitoring system, tail gas/biochemical analyzer, animal and plant culture, sanitary pump valve, fluid equipment, centrifuge, electrochemical analysis instrument, shaking table, bioreactor, carbon dioxide incubator, high-pressure sterilization pot, circulating cooling water machine, air compressor, cell crusher, high-pressure homogenizer, freeze dryer, spray dryer, centrifugal concentrator, biochemical analyzer, pharmaceutical packaging equipment, pharmaceutical machinery equipment Pharmaceutical wastewater treatment equipment, etc.

• Company:Shanghai Maoxu Exhibition Service Co., Ltd
• Truename:Ke Yang
• Mobile:18817211827
• Address:2345 Longyang Road, Pudong New Area, Shanghai

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870